• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

lavinia.spain@unimelb.edu.au

Credentials


Position
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-9356-8812

Dr Lavinia Spain

Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology

114 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma – The early Australian experience
    DOI: 10.1016/j.ejca.2026.116865
  • 2026

    Journal article

    Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
    DOI: 10.1016/j.eururo.2026.03.024
  • 2026

    Journal article

    Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.
    DOI: 10.1038/s41467-026-74076-y
  • 2026

    Journal article

    Real world outcomes of neoadjuvant immune checkpoint blockade (ICB) for resectable stage III melanoma: Pathologic response and FDG PET/CT correlates.
    DOI: 10.1200/jco.2026.44.16_suppl.9569
  • 2026

    Journal article

    Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
    DOI: 10.1001/jamanetworkopen.2026.7030
  • 2026

    Journal article

    [177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study
    DOI: 10.1016/S1470-2045(26)00017-3
  • 2026

    Journal article

    Development of a Digital Phenotype for Immune-Related Colitis
    DOI: 10.1200/CCI-25-00366
Lavinia Spain

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    CYTOSHRINK: A randomized phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with ipilimumab/nivolumab for metastatic kidney cancer.
    DOI: 10.1200/JCO.2026.44.7_suppl.416
  • 2026

    Journal article

    Treatment preferences of patients and physicians for early-stage and adjuvant treatment of urothelial carcinoma and renal cell carcinoma in Asia-Pacific: a discrete choice experiment.
    DOI: 10.1186/s12894-025-02043-8
  • 2025

    Journal article

    Patterns of recurrence after lymphadenectomy for melanoma lymph node metastasis at high risk of recurrence in the modern era of adjuvant systemic therapy.
    DOI: 10.1016/j.ejso.2025.111135

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224